Article info
PDFCorrespondence
Response to ‘Adverse cardiac outcomes in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors’
- Correspondence to Dr Darryl Leong, Population Health Research Institute, McMaster University, Hamilton L8L 2X2, Ontario, Canada; leongd{at}phri.ca
Citation
Response to ‘Adverse cardiac outcomes in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors’
Publication history
- First published June 30, 2021.
Online issue publication
September 24, 2021
Article Versions
- Previous version (30 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.